4.1 Article

Inpatient and outpatient costs associated with respiratory syncytial virus in Japanese infants and older adults

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Occurrence and disease burden of respiratory syncytial virus and other respiratory pathogens in adults aged ≥65 years in community: A prospective cohort study in Japan

Daisuke Kurai et al.

Summary: This study investigated the frequency and clinical profile of respiratory syncytial virus (RSV)-acute respiratory disease (ARD) in older adults in Japan. RSV was reported as a major pathogen for respiratory infections in older adults, with common symptoms including cough, sore throat, nasal congestion, and expectoration.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2022)

Article Pediatrics

Epidemiology of respiratory syncytial virus in Japan: A nationwide claims database analysis

Yasuhiro Kobayashi et al.

Summary: The study revealed that roughly one-fourth of RSV patients under 2 years old required hospitalization, with 90% of them lacking underlying risk factors. The incidence and hospitalization rates were higher among infants under 6 months old, indicating the need for specific prevention strategies targeting this age group.

PEDIATRICS INTERNATIONAL (2022)

Article Economics

Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age Groups

Ellen Rafferty et al.

Summary: RSV is a common and expensive infection at all ages, and the development of immunization programs targeting older adults and infants may be crucial in reducing the burden and cost of RSV.

PHARMACOECONOMICS (2022)

Article Infectious Diseases

RSV testing practice and positivity by patient demographics in the United States: integrated analyses of MarketScan and NREVSS databases

Phuong T. Tran et al.

Summary: This study aimed to describe testing practices and test positivity among a national sample of private health insurance enrollees in the US and illustrated the possible magnitude of misclassification when using national Surveillance Systems (NREVSS) to correct for RSV under ascertainment. The results showed that RSV-test positivity depends on the characteristics of patients for whom those tests were ordered, and using NREVSS positivity to correct for untested acute respiratory infections can lead to significant biases.

BMC INFECTIOUS DISEASES (2022)

Article Pediatrics

Hospitalisations due to respiratory syncytial virus infection in children with Down syndrome before and after palivizumab recommendation in Japan

Keisuke Okamoto et al.

Summary: The study revealed an increase in the percentage of children with Down syndrome in Japan receiving Palivizumab, and a significant decrease in the RSV-associated hospitalization rate for children born between 2013-2015 without congenital heart disease and born at a gestational age >= 36 weeks.

ACTA PAEDIATRICA (2021)

Article Geriatrics & Gerontology

Respiratory Syncytial Virus Infection in Older Adults: An Under-Recognized Problem

Angela R. Branche et al.

DRUGS & AGING (2015)

Article Medicine, General & Internal

Respiratory syncytial virus infection in elderly and high-risk adults

AR Falsey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Review Geriatrics & Gerontology

Respiratory syncytial virus infection in elderly adults

AR Falsey et al.

DRUGS & AGING (2005)

Article Immunology

Risk factors for severe respiratory syncytial virus infection in elderly persons

EE Walsh et al.

JOURNAL OF INFECTIOUS DISEASES (2004)